Hospital Ramos Mejía is a hospital in Buenos Aires, Argentina.

During the past decade, Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS" are "HIV Infections" (2 trials). Many other conditions were trialed in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS" in a lesser frequency.

Most popular intervention types in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IL-2" (1 trials) and "Recombinant interleukin-2 (rIL-2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".